Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.9 USD | +1.02% | -6.57% | -11.73% |
May. 09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
May. 08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.73% | 775M | |
+4.16% | 111B | |
+11.45% | 105B | |
-13.00% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+3.42% | 13.7B | |
+37.06% | 12.45B |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- Insider Trends: REGENXBIO Sees 90 Days of Insider Buying Trend Scaling Back with Share Sale